Shionogi & Co., Ltd. (OTCMKTS:SGIOY – Get Rating) and Swire Pacific (OTCMKTS:SWRAY – Get Rating) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
Earnings & Valuation
This table compares Shionogi & Co., Ltd. and Swire Pacific’s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Shionogi & Co., Ltd. | $2.99 billion | 4.63 | $1.02 billion | N/A | N/A |
| Swire Pacific | $11.69 billion | 2.71 | $432.95 million | N/A | N/A |
Shionogi & Co., Ltd. has higher earnings, but lower revenue than Swire Pacific.
Volatility & Risk
Insider & Institutional Ownership
0.1% of Shionogi & Co., Ltd. shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Dividends
Shionogi & Co., Ltd. pays an annual dividend of $0.15 per share and has a dividend yield of 1.3%. Swire Pacific pays an annual dividend of $0.26 per share and has a dividend yield of 3.1%.
Profitability
This table compares Shionogi & Co., Ltd. and Swire Pacific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Shionogi & Co., Ltd. | 34.06% | 11.73% | 10.12% |
| Swire Pacific | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Shionogi & Co., Ltd. and Swire Pacific, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Shionogi & Co., Ltd. | 0 | 0 | 0 | 0 | N/A |
| Swire Pacific | 0 | 0 | 0 | 0 | N/A |
Summary
Shionogi & Co., Ltd. beats Swire Pacific on 6 of the 9 factors compared between the two stocks.
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
About Swire Pacific
Swire Pacific Limited engages in property, aviation, beverages, marine, and trading and industrial businesses in Hong Kong, Mainland China, rest of Asia, the United States, and internationally. The company's Property division develops, owns, and operates mixed-use properties. This division's property investment portfolio comprises office and retail premises, serviced apartments, other luxury residential accommodations, and commercial mixed-use developments; and trading portfolio consists of residential properties. It also owns and manages two hotels in Hong Kong and four hotels in Mainland China, as well as owns interests in the Mandarin Oriental hotel in the United States. The company's Aviation division provides flight catering and ramp, passenger and cargo services, and aircraft maintenance and modification services. As of December 31, 2021, it had a fleet of 234 aircraft. Its Beverages division owns rights to manufacture, market, and distribute refreshing soft drinks to consumers. The company's Trading & Industrial division retails and distributes footwear, apparel, and accessories through its 164 retail outlets; sells passenger cars, commercial vehicles, motorcycles, and scooters; operates a chain of 538 bakery stores; packages and sells sugar products under the Taikoo Sugar brand; and offers waste management services. The company was founded in 1816 and is based in Central, Hong Kong.
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
